RBC Bearings Beats Expectations, Hologic Receives FDA Clearance, Cantor Fitzgerald Bullish on Bitfarms
- May 19th, 2023
- 544 views
RBC Bearings Incorporated (NYSE: RBC) has released its fourth-quarter fiscal 2023 earnings report, surpassing consensus expectations. The company reported an EPS of $2.13, exceeding the consensus estimate of $1.99.
In pre-market, $RBC is currently trading at $228.01, experiencing a notable increase of $3.67 (+1.64%).
Hologic Inc. (Nasdaq: HOLX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Panther Fusion SARS-CoV-2/Flu A/B/RSV assay. This molecular diagnostic test can detect and differentiate four of the most common respiratory viruses, namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A (flu A), influenza B (flu B), and respiratory syncytial virus (RSV).
Following the announcement, $HOLX is trading at $82.45 in pre-market, reflecting an increase of $1.39 (+1.71%).
Bitfarms Ltd. (Nasdaq: BITF) has been initiated with an Overweight rating and a price target of $2 by Cantor Fitzgerald.
$BITF is currently trading at $1.20 in pre-market, showing a rise of $0.05 (+4.35%).
Please note that the stock prices and pre-market movements mentioned here are for illustrative purposes and may not reflect the current market conditions at the time of reading.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
A Preview: Oracle, Franco-Nevada, and Asana Earnings Due
March 09th, 2025NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025
Member Login